Septerna, Inc. (SEPN)
(Delayed Data from NSDQ)
$15.70 USD
-0.24 (-1.51%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $15.72 +0.02 (0.13%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SEPN 15.70 -0.24(-1.51%)
Will SEPN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SEPN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SEPN
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?
ETFs to Capitalize on the Novo Nordisk-Septerna Deal
SEPN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk
Wall Street Analysts Predict a 207.31% Upside in Septerna, Inc. (SEPN): Here's What You Should Know
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
Other News for SEPN
Is SEPN gaining bullish strength? Expansion Breakout shows up after rallying 10.77%
SEPN forms Shooting Star Candlestick on September 17
NR7 appears for SEPN after 0.21% move
The technical outlook for SEPN is unchanged after it rises 1.33% on September 15
NR7 appears for SEPN after 0.97% move